ASCIA e-news update - Issue No 186 – 13 June 2017

ASCIA e-news update
  email


Issue No 186 | 13 June 2017

 
--
     

 

 

Inside this issue:

---

3 second EpiPen®s are now available

EpiPen® and EpiPen® Jr adrenaline (epinephrine) autoinjectors with the 3 second label will start to enter pharmacies in Australia and New Zealand from today (13 June 2017) onwards.  

The devices have not changed, just the instructions on the label, which now include:

  • Reduced injection time from 10 to 3 seconds – this is based on research confirming efficacy and delivery of adrenaline through the 3 second delivery.
  • Removal of the massage step after the injection – this has been found to reduce the risk of tissue irritation.

EpiPen®s with a 10 second label can continue to be used and should not be replaced unless they have been used, are just about to expire or have expired.   All EpiPen®s should now be held in place for 3 seconds, regardless of the instructions on the label.  However, if they are held for 10 seconds it will not affect the way that the adrenaline works. 

To access updated ASCIA Action Plans for Anaphylaxis, ASCIA anaphylaxis e-training courses, the 3 second EpiPen® training video and other resources go to www.allergy.org.au/anaphylaxis  

ASCIA AAP updates

Reminder: ASCIA 2017 Conference registration and abstract submission are now open  

With an outstanding program featuring 8 international speakers and a venue located on the spectacular Waitematā Harbour in Auckland, this conference is sure to be a highlight of the year for ASCIA members and other health professionals with an interest in allergy and clinical immunology.

Please note that the deadline for abstract submission and discounted earlybird registration is Friday 14 July 2017.

To register go to www.ascia2017.com.au/registration/

To submit a poster or CGR abstract go to www.ascia2017.com.au/call-for-abstracts/

To view the program go to www.ascia2017.com.au/preliminary-program/

For other information about the conference go to www.ascia2017.com.au

For information on what to see and do in New Zealand (pre or post conference) visit www.newzealand.com/au/ 

Updated and new ASCIA patient information for review

ASCIA has recently undertaken a large systemic review of ASCIA patient information (around 90 articles) on the ASCIA website.  As a result of this process the following 4 updated articles and 1 new article are now available for to review on the members section of the ASCIA website www.allergy.org.au/members/draft-documents-for-review:

  • Angioedema
  • Autoimmune diseases
  • Cow’s milk allergy
  • Hives (Urticaria)
  • Vasculitis disorders - new

Please email your feedback to education@allergy.org.au by Monday 26 June 2017.

Proposed changes to MBS skin testing item numbers for review

As part of the Medical Benefits Schedule (MBS) Review, recommendations regarding proposed changes to MBS skin testing item numbers 12003, 12000, 21981 and 53600 are available for review on the MBS review website in Section 5.3 www.mbsreview.com.au/reports/daicc-report-6.html#_Toc484007769  

Please email feedback to education@allergy.org.au by Monday 17 July 2017.  This feedback will be collated and sent by ASCIA to the MBS by the due date of Friday 21 July 2017 using the survey on the MBS review website. 

The survey questions that relate to allergy testing are as follows:

Recommendation 3 – Allergy (refer to Section 5.3.1) - Do you agree with Recommendation 3 which proposes to remove item 12003 for testing more than 20 allergens and consolidate under item 12000 as part of the changes being made to this item?

Recommendation 3.1 – Allergy (refer to Section 5.3.2) - Do you agree with Recommendation 3.1 which proposes to split item 12000 and change item 21981 in to four items that more accurately describe the allergens tested and the scope of practice required for each? 

Recommendation 3.2 – Allergy (refer to Section 5.3.3 - Do you agree with Recommendation 3.2 which proposes to remove item 53600?

Cutaneous granuloma in ataxia telangiectasia research study

A research project in Queensland aims to better understand cutaneous granuloma in ataxia telangiectasia (AT). 

The first phase of this project is to establish the prevalence and characteristics of this condition in the Australasian paediatric AT patient cohort, by reaching out to the Immunology and Dermatology community. Could you please help by completing a short (5 question) survey by Tuesday 4 July 2017 www.surveymonkey.com/r/CZRNWGB  

Meetings and events 201

Saturday 29 July 2017: ASCIA Advanced Training Meeting (Environmental Allergy), RACP Education Centre Sydney. To register email admin@allergy.org.au 

Monday 10 to Tuesday 11 August 2017: Rhinoscopy Workshop - St Vincent’s Hospital Sydney www.svhs.org.au/home/research-education/education/courses-workshops-and-conferences/medical/rhinoscopy-workshop-2017  

Saturday 12 August 2017: 4th Biennial Brisbane Vasculitis Symposium - an initiative of ARA & ASCIA (QLD) - Translational Research Institute, 37 Kent St, Brisbane. To register email cambarret@optusnet.com.au 

Tuesday 12 September 2017: CFAR Symposium – Viaduct Events Centre Auckland 
Wednesday 13 to Friday 15 September 2017: ASCIA 2017 Conference – Viaduct Events Centre Auckland 
Saturday 16 September 2017: Dietitians Food Allergy introductory course - Viaduct Events Centre Auckland 
www.ascia2017.com.au

Saturday 16 September 2017: ANZAAG Symposium – Maritime Room Auckland www.anzaag.com/Events.aspx  

A detailed list of other events is available on the ASCIA website: www.allergy.org.au/conferences/calendar

 
  ---  
  Jill Smith | CEO | Australasian Society of Clinical Immunology and Allergy Limited (ASCIA)
Suite 238, 117 Old Pittwater Road, Brookvale NSW 2100 Australia
p 02 8039 2140 | m 04252 16402
jill@allergy.org.au | w www.allergy.org.au 
 
  ---  
  ASCIA 2017 Conference – save the dates  
 
--